mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
2e-12 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-11 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
2e-11 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-11 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-11 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
4e-11 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
0.24 |
5e-11 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-10 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-10 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-10 |